TY  - EJOU
AU  - Jr., Sam D. Graham, 
AU  - Warden, Mary Elizabeth 
AU  - Lou, Jeffrey 

TI  - Molecular targeted therapies for renal cell carcinoma
T2  - Canadian Journal of Urology

PY  - 2007
VL  - 14
IS  - Suppl.6
SN  - 1488-5581

AB  - New advances in technology to directly target specific
molecular events in the proliferation of cancer have led to
promising results in renal cell carcinoma. Response rates
in excess of 70% and complete responses in advanced
(metastatic) renal cell carcinoma have caused a change in
the paradigm of treatment from immunotherapy. Toxicities
are significant, but manageable and pushing the toxicity to
tolerability may increase the response rate.
KW  - renal cell carcinoma
KW  -  metastatic
KW  -  therapy
KW  -  molecular

DO  -